Some Medicare enrollees will see thousands in savings. A new cap on prescription drugs goes into effect this year.

In Upslope’s view, CRL is a cyclical compounder going through a…cyclical downturn. Why are we bullish CRL stock? Click here ...

The global health landscape is constantly challenged by the emergence and re-emergence of viral pathogens. While significant progress has been made in ...

For the uninitiated, Recursion wants to become the go-to provider of AI-based drug discovery and development services for the ...

In an intensive Wintersession course at Brown, undergraduates learned lab techniques and performed experiments as they sought ...

Although anatomic imaging will remain important, molecular imaging provides several new opportunities to make the process of drug development more efficient. Various techniques for molecular ...

A report in the journal Science from researchers in the UW–Madison Department of Chemistry represents a significant advance ...

The Food and Drug Administration (FDA) has recently released two draft guidance documents (Artificial Intelligence-Enabled Device Software ...

The funding will support several central Alabama entities working to advance the state’s biotechnology ecosystem and impact.

Inhibition of group IVA cytosolic phospholipase A2 (cPLA2α) is a potential approach for cancer treatment. Here, the authors report thiazolyl ketone inhibitors of cPLA2α starting from compound ...

CfPIE’s Newest Instructor Aditi Khurana Meet Our Newest Director, Aditi Khurana: Integrating Artificial Intelligence into Biotech and Drug Development CHESTER SPRINGS, PA, UNITED STATES, Januar ...

Her passion lies in educating professionals on the transformative potential of AI in drug development. Introducing CfPIE's Newest Course: Generative AI in Drug Discovery & Development Leveraging ...